Table 3.
Variable | Effect Magnitude | p-Value | Confidence Interval |
---|---|---|---|
Sex * | 0.111 | 0.270 | −0.086 to 0.309 |
Smoking history | −0.191 | 0.089 | −4.110 to 0.029 |
Ethnicity (Black vs. White) |
0.090 | 0.308 | −0.830 to 0.264 |
Ethnicity (All other vs. White) |
0.117 | 0.233 | 0.075 to 0.309 |
Cancer stage (III/IV vs. I/II) |
−0.154 | 0.090 | −0.333 to 0.024 |
Histology (adeno vs. non) |
−0.057 | 0.619 | −0.280 to 0.166 |
Steroid use | −0.248 | 0.043 | −0.488 to −0.008 |
Chemotherapy | −0.186 | 0.033 | −0.358 to −0.015 |
Targeted Therapy | −0.113 | 0.347 | −0.350 to 0.123 |
Immune therapy | −0.009 | 0.912 | −0.165 to 0.148 |
Influenza vax | 0.330 | <0.001 | 0.150 to 0.509 |
SARS-CoV-2 booster | 0.412 | <0.001 | 0.291 to 0.534 |
SARS-CoV-2 infection | 0.276 | <0.001 | 0.128 to 0.425 |
Negative effects (those associated with decreased titers) are indicated in red. Significant findings are bolded. * Nonlinear effects of “Time after full vaccination” and “Age” on titers are shown in Supplemental Table S3.